Clinicopathologic and Molecular Characterization of NUP98‐Rearranged Acute Leukemias
- 21 January 2025
- journal article
- research article
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 47 (3) , 445-453
Abstract
Introduction: NUP98 rearrangements are rare in acute leukemias and portend a poor prognosis.Methods: This study explored clinicopathologic and molecular features of five patients with NUP98 rearranged (NUP98‐r) acute leukemias, including three females and two males with a median age of 34 years.Results: NUP98 fusion partners were associated with distinctive leukemia characteristics and biology. Three patients had NUP98::NSD1‐r acute myeloid leukemia (AML, all cytogenetically cryptic and with concomitant FLT3‐ITD) and unfavorable prognoses (in two patients), one patient had NUP98::HOXA9‐r AML with morphologic and immunophenotypic features resembling acute promyelocytic leukemia, and lastly, one patient had previously underreported NUP98::MLLT1‐r B/T mixed phenotype acute leukemia. After a median follow‐up of 24.7 months, median overall survival was 30 months and three of five patients (60%) remained in complete remission at the last follow‐up.Conclusion: Our study expands the clinical and molecular spectrum of NUP98‐r acute leukemias and recommends FISH testing for NUP98 rearrangement on those leukemia cases without recurrent gene rearrangements and/or normal karyotype followed by molecular confirmation to improve timely diagnosis and clinical management.Keywords
This publication has 30 references indexed in Scilit:
- Genomic heterogeneity within B/T mixed phenotype acute leukemia in a context of an immunophenotypeLeukemia Research Reports, 2023
- Combined treatment with venetoclax, dasatinib, and FLT3 inhibitors for NUP98‐NSD1+/FLT3‐ITD+ acute myeloid leukemia: A pediatric case reportPediatric Blood & Cancer, 2023
- Acute myeloid leukemia patients with NUP98::NSD1 showing initially poor treatment response can benefit from FLT3 inhibitors and venetoclax as well as HSCTAnnals of Hematology, 2022
- Distinct pathologic feature of myeloid neoplasm with t(v;11p15); NUP98 rearrangementHuman Pathology, 2022
- Mixed phenotype acute leukemia in a child associated with a NUP98‐NSD1 fusion and NRAS p.Gly61Arg mutationCancer Reports, 2021
- Faggot cells in acute myeloid leukemia with t(7;11)(p15;p15) and NUP98-HOXA9 fusionAnnals of Hematology, 2020
- NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosisLeukemia, 2016
- Clinical and laboratory studies of 17 patients with acute myeloid leukemia harboring t(7;11)(p15;p15) translocationLeukemia Research, 2013
- NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression patternLeukemia, 2013
- Cleave to LeaveMolecular Cell, 2002